(Q54004293)

23 May 2018

title

Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. (English)

1 reference

23 May 2018

author name string

Murphy KL

1

1 reference

23 May 2018

Kittrell FS

2

1 reference

23 May 2018

Gay JP

3

1 reference

23 May 2018

Jäger R

4

1 reference

23 May 2018

Medina D

5

1 reference

23 May 2018

Rosen JM

6

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

23 May 2018

published in

Oncogene

1 reference

23 May 2018

volume

18

1 reference

23 May 2018

issue

47

1 reference

23 May 2018

page(s)

6597-6604

1 reference

23 May 2018

Bcl-2 inhibits p53 nuclear import following DNA damage

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Kinetics of mammary epithelial cell proliferation in pituitary isografted BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Mediation of c-Myc-induced apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

The proto-oncogene Bcl-2 and its role in regulating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

Diminished cell proliferation associated with the death-protective activity of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

7 January 2021

Expression of p53 and bcl-2 in correlation to clinicopathological parameters, hormone receptor status and DNA ploidy in breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

7 January 2021

Pentagon medical school threatened again

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

7 January 2021

Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

7 January 2021

The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

7 January 2021

bcl-2 expression in the spectrum of preinvasive breast lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203099

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203099

1 reference

23 May 2018

1 reference

23 May 2018